For patients with the most common type of noninvasive breast cancer, routine testing for estrogen and progesterone receptors in tissue taken at the first "needle" biopsy is both unnecessary and ...
Initial hormone receptor tests for patients with the most common type of noninvasive breast cancer are not only unnecessary but could be costing U.S. hospitals tens of millions of dollars per year in ...
This study recruited 65 women of whom 94% were node-positive, and 60% were hormone receptor-negative. The pCR rate was 41.5% and 53.8% for the whole cohort and the hormone receptor–negative subgroup, ...
A fine-needle aspiration biopsy may be done by an internist, family medicine doctor, radiologist, or a general surgeon. The biopsy may be done in your doctor's office, a clinic, or the hospital. You ...
Most breast cancers are found with breast imaging, but the majority of "suspicious" breast lesions need more evaluation. This is known as a diagnostic workup, and there are two main methods: biopsy ...
Marissa Lawson receives funding from grant number T32CA09168 from the National Institutes of Health. Christoph Lee does not work for, consult, own shares in or receive funding from any company or ...